List of articles with "PeproMene Bio"

CAR T Therapy Data at ASH 2025

CAR T Therapy Data at ASH 2025

USA Irvine PeproMene Bio PMB-CT01 ASH 2025
ASH 2025 Presentations

ASH 2025 Presentations

USA Irvine PeproMene Bio PMB-CT01 BAFFR-CAR T
PeproMene at ASH 2025

PeproMene at ASH 2025

USA Irvine PeproMene Bio PMB-CT01 ASH 2025
PMB-CT01 Presentation

PMB-CT01 Presentation

USA Irvine PeproMene Bio PMB-CT01 BAFFR-CAR T
PMB-CT01 at ASH 2025

PMB-CT01 at ASH 2025

USA Irvine B-ALL PeproMene Bio B-NHL
Full Remission Achieved!

Full Remission Achieved!

USA Irvine CAR-T therapy Follicular Lymphoma PeproMene Bio
Breakthrough in Follicular Lymphoma

Breakthrough in Follicular Lymphoma

USA California CAR-T therapy Follicular Lymphoma PeproMene Bio
Lymphoma Breakthrough

Lymphoma Breakthrough

USA Irvine Follicular Lymphoma PeproMene Bio BAFF-R CAR-T
CAR-T Therapy Success

CAR-T Therapy Success

USA Irvine Follicular Lymphoma PeproMene Bio BAFF-R CAR-T
CAR-T Cell Breakthrough

CAR-T Cell Breakthrough

USA Irvine Follicular Lymphoma PeproMene Bio BAFF-R CAR-T
Investment for Lymphoma Treatment

Investment for Lymphoma Treatment

USA Irvine, California PeproMene Bio IFLI PMB-CT01
CAR-T Therapy Investment

CAR-T Therapy Investment

USA Irvine PeproMene Bio IFLI PMB-CT01
Lymphoma Therapy Funding

Lymphoma Therapy Funding

United States Irvine PeproMene Bio IFLI PMB-CT01
PeproMene Bio Secures $11M

PeproMene Bio Secures $11M

USA CAR T Therapy Follicular Lymphoma Irvine, California PeproMene Bio
PeproMene $11M Investment

PeproMene $11M Investment

USA Irvine CAR T Therapy Follicular Lymphoma PeproMene Bio

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.